<code id='3BBAA47FA2'></code><style id='3BBAA47FA2'></style>
    • <acronym id='3BBAA47FA2'></acronym>
      <center id='3BBAA47FA2'><center id='3BBAA47FA2'><tfoot id='3BBAA47FA2'></tfoot></center><abbr id='3BBAA47FA2'><dir id='3BBAA47FA2'><tfoot id='3BBAA47FA2'></tfoot><noframes id='3BBAA47FA2'>

    • <optgroup id='3BBAA47FA2'><strike id='3BBAA47FA2'><sup id='3BBAA47FA2'></sup></strike><code id='3BBAA47FA2'></code></optgroup>
        1. <b id='3BBAA47FA2'><label id='3BBAA47FA2'><select id='3BBAA47FA2'><dt id='3BBAA47FA2'><span id='3BBAA47FA2'></span></dt></select></label></b><u id='3BBAA47FA2'></u>
          <i id='3BBAA47FA2'><strike id='3BBAA47FA2'><tt id='3BBAA47FA2'><pre id='3BBAA47FA2'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:7756
          Adobe

          Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

          Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

          advertisement

          Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more
          FDA panel endorses Alnylam’s heart drug — after picking it apart
          FDA panel endorses Alnylam’s heart drug — after picking it apart

          KristofferTripplaar/SipaUSA/APAgroupofadviserstotheFoodandDrugAdministrationvotedinfavorofAlnylamPha

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Dramatically reducing cancer deaths requires the PASTEUR Act

          ThesuperbugStaphylcocusepidermidisisshownonanagarplate.Morethan3millionAmericansdevelopadrug-resista